Cite

HARVARD Citation

    Goss, G. et al. (2016). A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies. Journal of translational medicine. 14 (1), pp. 1-11. [Online]. 
  
Back to record